Make your money go further for just 25p per day

PREMIUM
AIM IHT

Benefit from the boom in healthcare Artificial Intelligence (Updated)

AI imagery

This Artificial Intelligence data analytics company, with considerable expertise in neuroscience, has been growing fast over recent years and looks compelling value. Our in-depth commentary here highlights its appeal in a sector which is predicted to grow significantly over the coming years. The growing order book offers plenty of visibility and this fascinating business is certainly worth a close look. (IHT qualifying)


IXICO (LON:IXI) is an Artificial Intelligence (‘AI’) data analytics company delivering intelligent insights in neuroscience. Its purpose is to advance medicine and human health in neuroscience by converting raw clinical trial data into clinically meaningful information.


Through the deployment of novel Artificial Intelligence (‘AI’) algorithms, IXICO analyses and interprets brain scans and wearable biosensor data to enable better trial design, patient selection and ultimately better clinical outcomes across all phases of clinical evaluation.

The Group is a…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

Have your say

Log in or register to view or add comments.

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on IXICO PLC

Steaming ahead

22/09/2021 · Company Insights

While some companies covered here are still in recovery mode, others have demonstrated admirable resilience and…


Shares soar, but is there more to go for?

08/09/2021 · Company Insights

Fabulous results and a very positive outlook statement brought substantial upgrades for this high margin business…


More Company Insights

Bonkers Bargains: a rare find (Updated)

15/10/2021

Stonking Small Caps: this roller coaster is on the up (Updated)

15/10/2021